Mesothelioma Chemotherapy Drug Alimta Continues to Benefit Mesothelioma Patients – Asbestos.com
|
Mesothelioma Chemotherapy Drug Alimta Continues to Benefit Mesothelioma Patients
Asbestos.com Recent clinical trials in trimodality therapy continue to prove the efficacy of Alimta (pemetrexed) when combined with cisplatin in mesothelioma patients. … Time Running out to Apply for Fellowship Award for the Research of … |
